Biologics Tied to Lower Eye Risk in Psoriasis

Real-world data suggest lower rates of ocular surface disease with biologics vs nonbiologic systemic therapy.

• By

• Andrea Surnit

• April 20, 2026

• 2 min

• MDSpire News